Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL BIOTECH INGREDIENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL BIOTECH INGREDIENT MARKET SIZE
2.3 VENDOR POSITIONING GRID
2.4 MARKETS COVERED
2.5 GEOGRAPHIC SCOPE
2.6 YEARS CONSIDERED FOR THE STUDY
2.7 RESEARCH METHODOLOGY
2.8 TECHNOLOGY LIFE LINE CURVE
2.9 MULTIVARIATE MODELLING
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET APPLICATION COVERAGE GRID
2.13 DBMR MARKET CHALLENGE MATRIX
2.14 SECONDARY SOURCES
2.15 GLOBAL BIOTECH INGREDIENT MARKET: RESEARCH SNAPSHOT
2.16 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 PRICE INDEX OVERVIEW
5 EXECUTIVE SUMMARY
6 PREMIUM INSIGHTS
6.1 RAW MATERIAL COVERAGE
6.2 PRODUCTION CONSUMPTION ANALYSIS
6.3 IMPORT EXPORT SCENARIO
6.4 TECHNOLOGICAL ADVANCEMENT BY MANUFACTURERS
6.5 PORTER’S FIVE FORCES
6.6 VENDOR SELECTION CRITERIA
6.7 PESTEL ANALYSIS
6.8 REGULATION COVERAGE
6.8.1 PRODUCT CODES
6.8.2 CERTIFIED STANDARDS
6.8.3 SAFETY STANDARDS
6.8.3.1. MATERIAL HANDLING & STORAGE
6.8.3.2. TRANSPORT & PRECAUTIONS
6.8.3.3. HARAD IDENTIFICATION
7 SUPPLY CHAIN ANALYSIS
7.1 OVERVIEW
7.2 LOGISTIC COST SCENARIO
7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
8 CLIMATE CHANGE SCENARIO
8.1 ENVIRONMENTAL CONCERNS
8.2 INDUSTRY RESPONSE
8.3 GOVERNMENT’S ROLE
8.4 ANALYST RECOMMENDATIONS
9 GLOBAL BIOTECH INGREDIENT MARKET, BY TYPE, (2020-2029), (USD MILLION) (TONS)
(VALUE, VOLUME AND ASP FOR EACH SEGMENT WILL BE PROVIDED)
9.1 OVERVIEW
9.2 INNOVATIVE BIOTECH APIS
9.2.1 ASP
9.2.2 VALUE
9.2.3 VOLUME
9.3 GENERIC BIOTECH APIS/ BIOSIMILARS
9.3.1 ASP
9.3.2 VALUE
9.3.3 VOLUME
10 GLOBAL BIOTECH INGREDIENT MARKET, BY PRODUCT, (2020-2029), (USD MILLION) (TONS)
(VALUE, VOLUME AND ASP FOR EACH SEGMENT WILL BE PROVIDED)
10.1 OVERVIEW
10.2 MONOCLONAL ANTIBODIES
10.2.1 ASP
10.2.2 VALUE
10.2.3 VOLUME
10.3 VACCINES
10.3.1 ASP
10.3.2 VALUE
10.3.3 VOLUME
10.4 HORMONES AND GROWTH FACTORS
10.4.1 ASP
10.4.2 VALUE
10.4.3 VOLUME
10.5 CYTOKINES
10.5.1 ASP
10.5.2 VALUE
10.5.3 VOLUME
10.6 FUSION PROTEINS
10.6.1 ASP
10.6.2 VALUE
10.6.3 VOLUME
10.7 THERAPEUTIC ENZYMES
10.7.1 ASP
10.7.2 VALUE
10.7.3 VOLUME
10.8 BLOOD FACTORS
10.8.1 ASP
10.8.2 VALUE
10.8.3 VOLUME
10.9 OTHERS
10.9.1 ASP
10.9.2 VALUE
10.9.3 VOLUME
11 GLOBAL BIOTECH INGREDIENT MARKET, BY EXPRESSION SYSTEM, (2020-2029), (USD MILLION) (TONS)
(VALUE, VOLUME AND ASP FOR EACH SEGMENT WILL BE PROVIDED)
11.1 OVERVIEW
11.2 MAMMALIAN
11.2.1 ASP
11.2.2 VALUE
11.2.3 VOLUME
11.3 MICROBIAL
11.3.1 ASP
11.3.2 VALUE
11.3.3 VOLUME
11.4 YEAST
11.4.1 ASP
11.4.2 VALUE
11.4.3 VOLUME
11.5 PLANT
11.5.1 ASP
11.5.2 VALUE
11.5.3 VOLUME
11.6 INSECT
11.6.1 ASP
11.6.2 VALUE
11.6.3 VOLUME
11.7 OTHERS
11.7.1 ASP
11.7.2 VALUE
11.7.3 VOLUME
12 GLOBAL BIOTECH INGREDIENT MARKET, BY APPLICATION, (2020-2029), (USD MILLION) (TONS)
(VALUE, VOLUME AND ASP FOR EACH SEGMENT WILL BE PROVIDED)
12.1 OVERVIEW
12.2 FOOD AND BEVERAGE
12.2.1 ASP
12.2.2 VALUE
12.2.3 VOLUME
12.2.4 FOOD AND BEVERAGE, BY TYPE
12.2.4.1. BAKERY PRODUCTS
12.2.4.2. ALCOHOLIC BEVERAGES
12.2.4.3. DIETARY SUPPLEMENTS
12.2.4.4. DAIRY PRODUCTS
12.2.4.5. CONFECTIONERIES
12.2.4.6. OTHERS
12.3 COSMETICS
12.3.1 ASP
12.3.2 VALUE
12.3.3 VOLUME
12.4 PHARMACEUTICAL
12.4.1 ASP
12.4.2 VALUE
12.4.3 VOLUME
12.5 OTHERS
12.5.1 ASP
12.5.2 VALUE
12.5.3 VOLUME
13 GLOBAL BIOTECH INGREDIENT MARKET, BY REGION, (2020-2029), (USD MILLION) (TONS)
GLOBAL BIOTECH INGREDIENT MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
13.2 EUROPE
13.2.1 GERMANY
13.2.2 U.K.
13.2.3 ITALY
13.2.4 FRANCE
13.2.5 SPAIN
13.2.6 RUSSIA
13.2.7 SWITZERLAND
13.2.8 TURKEY
13.2.9 BELGIUM
13.2.10 NETHERLANDS
13.2.11 REST OF EUROPE
13.3 ASIA-PACIFIC
13.3.1 JAPAN
13.3.2 CHINA
13.3.3 SOUTH KOREA
13.3.4 INDIA
13.3.5 SINGAPORE
13.3.6 THAILAND
13.3.7 INDONESIA
13.3.8 MALAYSIA
13.3.9 PHILIPPINES
13.3.10 AUSTRALIA & NEW ZEALAND
13.3.11 REST OF ASIA-PACIFIC
13.4 SOUTH AMERICA
13.4.1 BRAZIL
13.4.2 ARGENTINA
13.4.3 REST OF SOUTH AMERICA
13.5 MIDDLE EAST AND AFRICA
13.5.1 SOUTH AFRICA
13.5.2 EGYPT
13.5.3 SAUDI ARABIA
13.5.4 UNITED ARAB EMIRATES
13.5.5 ISRAEL
13.5.6 REST OF MIDDLE EAST AND AFRICA
14 GLOBAL BIOTECH INGREDIENT MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14.5 MERGERS AND ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT AND APPROVALS
14.7 EXPANSIONS
14.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 SWOT AND DATA BRIDGE MARKET RESEARCH ANALYSIS
16 GLOBAL BIOTECH INGREDIENT MARKET - COMPANY PROFILES
16.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
16.1.1 COMPANY SNAPSHOT
16.1.2 PRODUCT PORTFOLIO
16.1.3 PRODUCTION CAPACITY OVERVIEW
16.1.4 REVENUE ANALYSIS
16.1.5 RECENT UPDATES
16.2 BRISTOL-MYERS SQUIBB COMPANY
16.2.1 COMPANY SNAPSHOT
16.2.2 PRODUCT PORTFOLIO
16.2.3 PRODUCTION CAPACITY OVERVIEW
16.2.4 REVENUE ANALYSIS
16.2.5 RECENT UPDATES
16.3 LILLY
16.3.1 COMPANY SNAPSHOT
16.3.2 PRODUCT PORTFOLIO
16.3.3 PRODUCTION CAPACITY OVERVIEW
16.3.4 REVENUE ANALYSIS
16.3.5 RECENT UPDATES
16.4 GSK PLC
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 PRODUCTION CAPACITY OVERVIEW
16.4.4 REVENUE ANALYSIS
16.4.5 RECENT UPDATES
16.5 MERCK & CO
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 PRODUCTION CAPACITY OVERVIEW
16.5.4 REVENUE ANALYSIS
16.5.5 RECENT UPDATES
16.6 PFIZER INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 PRODUCTION CAPACITY OVERVIEW
16.6.4 REVENUE ANALYSIS
16.6.5 RECENT UPDATES
16.7 SANOFI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 PRODUCTION CAPACITY OVERVIEW
16.7.4 REVENUE ANALYSIS
16.7.5 RECENT UPDATES
16.8 ASTRAZENECA
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 PRODUCTION CAPACITY OVERVIEW
16.8.4 REVENUE ANALYSIS
16.8.5 RECENT UPDATES
16.9 MYLAN N.V
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 PRODUCTION CAPACITY OVERVIEW
16.9.4 REVENUE ANALYSIS
16.9.5 RECENT UPDATES
16.1 NOVARTIS AG
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 PRODUCTION CAPACITY OVERVIEW
16.10.4 REVENUE ANALYSIS
16.10.5 RECENT UPDATES
16.11 BIOMÉRIEUX
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 PRODUCTION CAPACITY OVERVIEW
16.11.4 REVENUE ANALYSIS
16.11.5 RECENT UPDATES
16.12 CEPHEID INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 PRODUCTION CAPACITY OVERVIEW
16.12.4 REVENUE ANALYSIS
16.12.5 RECENT UPDATES
16.13 BRUKER
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 PRODUCTION CAPACITY OVERVIEW
16.13.4 REVENUE ANALYSIS
16.13.5 RECENT UPDATES
16.14 LONZA
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 PRODUCTION CAPACITY OVERVIEW
16.14.4 REVENUE ANALYSIS
16.14.5 RECENT UPDATES
16.15 FIRMENICH SA.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 PRODUCTION CAPACITY OVERVIEW
16.15.4 REVENUE ANALYSIS
16.15.5 RECENT UPDATES
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
17 RELATED REPORTS
18 QUESTIONNAIRE
19 CONCLUSION
20 ABOUT DATA BRIDGE MARKET RESEARCH
